Showing results (1261-1270 of 2,492) with videos related to
Sort By:
Pageof 250
Expert Review of Vaccines|April 12, 2016
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studiesP Vici, L Pizzuti, L Mariani, et al.Expert Review of Vaccines|February 19, 2016
Therapeutic vaccines for prostate cancer: recent advances and future directionsJulius Strauss, Ravi A MadanExpert Review of Vaccines|July 9, 2015
Gold nanoparticles and vaccine developmentJorge Alberto Salazar-González, Omar González-Ortega, Sergio Rosales-MendozaExpert Review of Vaccines|January 28, 2025
Regulated microbe vaccines: from concept to (pre-clinical) reduction to practiceRichard Voellmy, David C Bloom, Nuria VilaboaExpert Review of Vaccines|December 18, 2024
Cost-effectiveness of bivalent respiratory syncytial virus prefusion F vaccine for prevention of respiratory syncytial virus among older adults in GermanyAhuva Averin, Bennet Huebbe, Mark Atwood, et al.Expert Review of Vaccines|December 17, 2024
Economic evaluation of childhood pneumococcal conjugate vaccination programs in Qinghai and Hainan provinces, ChinaHaonan Zhang, Chaofan Wang, Haijun Zhang, et al.Expert Review of Vaccines|November 14, 2024
Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environmentCharles Reynard, James Campling, Adam L Gordon, et al.Expert Review of Vaccines|April 3, 2020
Upper respiratory tract colonization with Streptococcus pneumoniae in adultsAdriano Arguedas, Krzysztof Trzciński, Katherine L O'Brien, et al.Expert Review of Vaccines|April 3, 2020
Residual colonization by vaccine serotypes in rural South Africa four years following initiation of pneumococcal conjugate vaccine immunizationShabir A Madhi, Susan A Nzenze, Marta C Nunes, et al.Expert Review of Vaccines|April 7, 2020
Protecting the most vulnerable age group: a review of MenACWY-TT immunogenicity and safety in infantsFederico Martinón-Torres, Lidia Serra, Marco Aurelio P SafadiPageof 250